Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Edward Nerio"'
Perifosine is an oral Akt inhibitor which exerts a marked cytotoxic effect on human tumor cell lines, and is currently being tested in several phase II trials for treatment of major human cancers. However, the efficacy of perifosine in human gliomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae61c1ff3e34105c61aa2206e2c7739
https://doi.org/10.1158/0008-5472.c.6493892
https://doi.org/10.1158/0008-5472.c.6493892
Supplementary Figure 2 from Perifosine Inhibits Multiple Signaling Pathways in Glial Progenitors and Cooperates With Temozolomide to Arrest Cell Proliferation in Gliomas In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2649c30bdfcb89289cbc61a35bd792ed
https://doi.org/10.1158/0008-5472.22363769
https://doi.org/10.1158/0008-5472.22363769
Supplementary Figure 1 from Perifosine Inhibits Multiple Signaling Pathways in Glial Progenitors and Cooperates With Temozolomide to Arrest Cell Proliferation in Gliomas In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129315696f321f448febdbc7bfc19831
https://doi.org/10.1158/0008-5472.22363772.v1
https://doi.org/10.1158/0008-5472.22363772.v1
Publikováno v:
Cancer Research. 65:7429-7435
Perifosine is an oral Akt inhibitor which exerts a marked cytotoxic effect on human tumor cell lines, and is currently being tested in several phase II trials for treatment of major human cancers. However, the efficacy of perifosine in human gliomas
Publikováno v:
Nature medicine. 10(11)
Bioluminescence imaging has previously been used to monitor the formation of grafted tumors in vivo and measure cell number during tumor progression and response to therapy. The development and optimization of successful cancer therapy strategies may
Publikováno v:
PLoS ONE. 2009, Vol. 4 Issue 9, p1-10. 10p. 2 Color Photographs, 3 Graphs.
Publikováno v:
Oncogene. 7/24/2008, Vol. 27 Issue 32, p4392-4401. 10p. 5 Color Photographs, 1 Chart, 1 Graph.
Publikováno v:
Neuro-Oncology; 2003, Vol. 5 Issue 4, p279-360, 82p